News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
337,671 Results
Type
Article (26856)
Company Profile (159)
Press Release (310646)
Multimedia
Podcasts (39)
Webinars (17)
Section
Business (91550)
Career Advice (1321)
Deals (14214)
Drug Delivery (90)
Drug Development (38473)
Employer Resources (160)
FDA (8081)
Job Trends (8639)
News (153966)
Policy (13556)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1982)
Academic (2)
Accelerated approval (19)
Adcomms (17)
Allergies (116)
Alliances (25357)
ALS (115)
Alzheimer's disease (1033)
Antibody-drug conjugate (ADC) (152)
Approvals (8351)
Artificial intelligence (338)
Autoimmune disease (88)
Automation (28)
Bankruptcy (97)
Best Places to Work (7324)
BIOSECURE Act (13)
Biosimilars (105)
Biotechnology (89)
Bladder cancer (104)
Brain cancer (30)
Breast cancer (362)
Cancer (2569)
Cardiovascular disease (252)
Career advice (1181)
Career pathing (39)
CAR-T (155)
CDC (24)
Celiac Disease (1)
Cell therapy (438)
Cervical cancer (22)
Clinical research (33484)
Collaboration (1086)
Compensation (436)
Complete response letters (28)
COVID-19 (1394)
CRISPR (65)
C-suite (608)
Cystic fibrosis (115)
Data (3955)
Decentralized trials (1)
Denatured (23)
Depression (86)
Diabetes (301)
Diagnostics (3525)
Digital health (25)
Diversity (10)
Diversity, equity & inclusion (39)
Drug discovery (156)
Drug pricing (88)
Drug shortages (6)
Duchenne muscular dystrophy (134)
Earnings (28258)
Editorial (25)
Employer branding (24)
Employer resources (138)
Events (51794)
Executive appointments (705)
FDA (10091)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (9)
Funding (983)
Gene editing (132)
Generative AI (31)
Gene therapy (400)
GLP-1 (510)
Government (2400)
Grass and pollen (2)
Guidances (220)
Healthcare (9882)
HIV (39)
Huntington's disease (27)
IgA nephropathy (62)
Immunology and inflammation (107)
Immuno-oncology (18)
Indications (52)
Infectious disease (1544)
Inflammatory bowel disease (138)
Inflation Reduction Act (9)
Influenza (61)
Intellectual property (122)
Interviews (198)
IPO (6435)
IRA (26)
Job creations (1578)
Job search strategy (1011)
JPM (31)
Kidney cancer (3)
Labor market (82)
Layoffs (225)
Leadership (25)
Legal (2186)
Liver cancer (51)
Longevity (12)
Lung cancer (324)
Lymphoma (235)
Machine learning (27)
Management (53)
Manufacturing (449)
MASH (77)
Medical device (6472)
Medtech (6501)
Mergers & acquisitions (8410)
Metabolic disorders (669)
Multiple sclerosis (95)
NASH (11)
Neurodegenerative disease (186)
Neuropsychiatric disorders (38)
Neuroscience (1818)
Neurotech (1)
NextGen: Class of 2026 (3668)
Non-profit (3477)
Now hiring (64)
Obesity (278)
Opinion (171)
Ovarian cancer (91)
Pain (125)
Pancreatic cancer (108)
Parkinson's disease (196)
Partnered (24)
Patents (206)
Patient recruitment (284)
Peanut (51)
People (34785)
Pharmaceutical (38)
Pharmacy benefit managers (7)
Phase 1 (9668)
Phase 2 (14401)
Phase 3 (12402)
Pipeline (3025)
Policy (138)
Postmarket research (1238)
Preclinical (4209)
Press Release (61)
Prostate cancer (142)
Psychedelics (28)
Radiopharmaceuticals (135)
Rare diseases (594)
Real estate (3239)
Recruiting (63)
Regulatory (11509)
Reports (47)
Research institute (1783)
Resumes & cover letters (167)
Rett syndrome (25)
RNA editing (11)
RSV (55)
Schizophrenia (99)
Series A (172)
Series B (115)
Service/supplier (7)
Sickle cell disease (69)
Special edition (11)
Spinal muscular atrophy (116)
Sponsored (30)
Startups (2394)
State (1)
Stomach cancer (8)
Supply chain (54)
Tariffs (19)
The Weekly (16)
Vaccines (470)
Venture capital (68)
Weight loss (168)
Women's health (48)
Worklife (20)
Date
Last 7 days (337)
Last 30 days (1248)
Last 365 days (17300)
2026 (1671)
2025 (17605)
2024 (20039)
2023 (22460)
2022 (27552)
2021 (30632)
2020 (28325)
2019 (25200)
2018 (18734)
2017 (16375)
2016 (15827)
2015 (17415)
2014 (12650)
2013 (10239)
2012 (10756)
2011 (11093)
2010 (10056)
Location
Africa (491)
Alabama (51)
Alaska (7)
Arizona (140)
Arkansas (9)
Asia (19447)
Australia (3512)
California (6205)
Canada (1718)
China (527)
Colorado (277)
Connecticut (282)
Delaware (260)
Europe (48663)
Florida (998)
Georgia (226)
Hawaii (3)
Idaho (24)
Illinois (445)
India (53)
Indiana (417)
Iowa (20)
Japan (345)
Kansas (63)
Kentucky (26)
Louisiana (18)
Maine (16)
Maryland (719)
Massachusetts (4743)
Michigan (180)
Minnesota (346)
Mississippi (6)
Missouri (64)
Montana (19)
Nebraska (11)
Nevada (72)
New Hampshire (21)
New Jersey (1929)
New Mexico (19)
New York (1760)
North Carolina (950)
North Dakota (9)
Northern California (3037)
Ohio (203)
Oklahoma (12)
Oregon (28)
Pennsylvania (1226)
Puerto Rico (13)
Rhode Island (25)
South America (631)
South Carolina (15)
Southern California (2365)
Tennessee (84)
Texas (842)
United States (22680)
Utah (148)
Vermont (1)
Virginia (133)
Washington D.C. (52)
Washington State (413)
West Virginia (2)
Wisconsin (92)
Wyoming (1)
337,671 Results for "anavex life sciences corp.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026
February 3, 2026
·
3 min read
Press Releases
Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology
January 8, 2026
·
5 min read
Press Releases
Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program
January 6, 2026
·
4 min read
Press Releases
Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion
December 19, 2025
·
4 min read
Press Releases
Anavex Life Sciences Provides Regulatory Update on Blarcamesine for Early Alzheimer’s Disease
November 17, 2025
·
5 min read
Press Releases
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease
December 15, 2025
·
4 min read
Press Releases
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference
November 20, 2025
·
3 min read
Press Releases
Anavex Life Sciences Reports Fiscal 2025 Fourth Quarter Financial Results and Provides Business Update
November 26, 2025
·
11 min read
Press Releases
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025
November 19, 2025
·
3 min read
Press Releases
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
November 27, 2025
·
6 min read
1 of 33,768
Next
